Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Benzazepines compounds serving as vasopressin receptor antagonism

A compound, benzoazepine technology, applied in the field of preparation of medicines for the treatment of vasopressin-related diseases, can solve the problems of difficulty in making injections, poor water solubility, etc., and achieve the effect of excellent water solubility

Active Publication Date: 2011-04-27
SHANGHAI HANSOH BIOMEDICAL
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the molecular structure of tolvaptan determines that its water solubility is relatively poor, and it is not easy to make injections. In order to overcome this shortcoming, the present invention has invented a new class of benzazepine compounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzazepines compounds serving as vasopressin receptor antagonism
  • Benzazepines compounds serving as vasopressin receptor antagonism
  • Benzazepines compounds serving as vasopressin receptor antagonism

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] N-[4-[5-(2-aminoacetoxy)-2,3,4,5-tetrahydro-1-benzazepine-1-formyl]-benzene represented by formula (V) The preparation of base]-2-methylbenzamide hydrochloride

[0028]

[0029] Include the following steps:

[0030] 1) Preparation of N-[4-[5-hydroxyl-2,3,4,5-tetrahydro-1-benzazepine-1-formyl]-phenyl]-2-methylbenzamide

[0031] N-[4-[5-oxo-2,3,4,5-tetrahydro-1-benzazepine-1-formyl]-phenyl]-2-methylbenzamide 2 g In 10ml of methanol and 10ml of THF mixture, add 0.8g of sodium borohydride twice at room temperature, stir for 1 hour after the addition, concentrate to remove the solvent, add 30ml of water to the residue, stir for 1 hour, filter, and dry to obtain a light yellow powder, MS- ESI: 401.5 [M+H].

[0032] 2) Preparation of N-[4-[5-(2-(N-tert-butoxycarbonyl)aminoacetoxy)-2,3,4,5-tetrahydro-1-benzazepine-1-methyl Acyl]-phenyl]-2-methylbenzamide hydrochloride

[0033] Add 494 mg of the product in 1), 475 mg of BOC-glycine to 20 ml of dichloromethane, add 500 mg...

Embodiment 2

[0037] N-[4-[5-(2-amino-3-methylbutyryloxy)-2,3,4,5-tetrahydro-1-benzazepine-1 represented by formula (VI) Preparation of -formyl]-phenyl]-2-methylbenzamide hydrochloride

[0038]

[0039] Following the same method as in Example 1, except that glycine was replaced by valine, an off-white solid was obtained, melting point: 183-185° C., MS-ESI: 501.5 [M+H].

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a benzazepines compounds serving as vasopressin receptor antagonism, in particular to a benzazepines compound shown in formula (I) or pharmaceutically acceptable salt thereof and a preparation method thereof, and a medicinal composition containing a compound containing curative dose of the compound or the pharmaceutically acceptable salt thereof, and application in preparing medicament for treating diseases related to the vasopressin thereof.

Description

technical field [0001] The present invention relates to a benzoazepine compound or a pharmaceutically acceptable salt thereof and a preparation method thereof, as well as a pharmaceutical composition containing a therapeutically effective amount of the compound or a pharmaceutically acceptable salt thereof, and its preparation for treatment and Use in medicine for vasopressin-related diseases. Background technique [0002] Vasopressin is a nonapeptide hormone mainly secreted by the posterior pituitary gland. The hormone acts through vascular V1 receptors and renal V2 receptor subtypes. The V2 receptors in the kidney can stimulate adenylate cyclase to achieve Urinary effect. Vasopressin receptor antagonists are widely used and can be used to treat the following diseases: hypertension, congestive heart failure, liver cirrhosis, renal failure, cerebral edema, etc. [0003] Benzoazepines are a class of small molecule vasopressin V2 receptor antagonists, and tolvaptan is the fi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D223/16A61K31/55A61P9/12A61P9/04A61P1/16A61P13/12A61P7/10
Inventor 岑均达唐家邓
Owner SHANGHAI HANSOH BIOMEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com